Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …

V Romanenko, I Osipova, A Galustyan… - Human Vaccines & …, 2020 - Taylor & Francis
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …

Immunogenicity, reactogenicity and safety of a combined DTPa-IPV vaccine compared with separate DTPa and IPV vaccines in healthy Korean infants

CH Kim, SH Cha, SM Shin, CS Kim… - Korean Journal of …, 2010 - synapse.koreamed.org
Purpose To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-
acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix™ IPV …

Booster vaccination and 1-year follow-up of 4–8-year-old children with a reduced-antigen-content dTpa-IPV vaccine

R Sänger, U Behre, KH Krause, HP Loch… - European journal of …, 2007 - Springer
Reduced-antigen-content pertussis vaccines designed initially for booster vaccination of
adolescents and adults can also be used to vaccinate pre-school age children. Combination …

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b …

Y Li, RC Li, Q Ye, C Li, YP Liu, X Ma, Y Li… - Human Vaccines & …, 2017 - Taylor & Francis
We conducted 3 phase III, randomized, open-label, clinical trials assessing the safety,
reactogenicity (all studies), immunogenicity (Primary vaccination study) and persistence of …

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III …

KH Kim, CS Kim, HM Kim, JD Kim, SH Ma… - Human Vaccines & …, 2019 - Taylor & Francis
We assessed the immunogenicity and safety of a three-dose primary vaccination schedule
with the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus …

Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination

S Meriste, E Tamm, P Willems… - Scandinavian journal of …, 1999 - Taylor & Francis
This study evaluated the safety and immunogenicity of combined diphtheria, tetanus,
acellular pertussis, inactivated poliomyelitis vaccine (DTPa-IPV) given as primary …

Safety and Reactogenicity of a Novel DTPa-HBV-IPV Combined Vaccine Given Along With Commercial Hib Vaccines inComparison With Separate Concomitant …

F Zepp, A Schuind, C Meyer, R Sänger… - …, 2002 - publications.aap.org
Objective. Combination vaccines simplify vaccine administration and have the potential to
promote compliance and cost-effectiveness by decreasing the number of injections needed …

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV …

M Avdicová, V Prikazský, H Hudecková… - European journal of …, 2002 - Springer
In an open randomised trial, 312 eligible infants were enrolled to receive either a single
injection of the hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated …

Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in …

DD Anh, O Van Der Meeren, N Karkada… - Human Vaccines & …, 2016 - Taylor & Francis
abstract The introduction of combination vaccines plays a significant role in increasing
vaccine acceptance and widening vaccine coverage. Primary vaccination against …

Safety and immunogenicity of a combined DTPa–IPV vaccine administered as a booster from 4 years of age: a review

JM Jacquet, P Bégué, E Grimprel, P Reinert, S Sandbu… - Vaccine, 2006 - Elsevier
A combined DTPa–IPV booster vaccine was administered as a 4th or 5th dose after DTPa or
DTPw priming. Over 99% vaccines developed antibody levels considered to be protective to …